Better technology, more life.

To achieve our goal of better technology, more life Memphasys combines qualified personnel, experience, and technology in reproductive biotechnology.

The driving force for Memphasys is the belief and desire to commercialise the Felix™ System as the global standard in sperm preparation for IVF.

Better technology, more life.

Memphasys Limited (ASX: MEM) is an Australian-based reproductive biotechnology company commercialising the Felix™ System, a patented bio separation technology that isolates the most viable sperm cells for human assisted reproduction.

For investor and media enquiries:
David Tasker, Chapter One Advisors
E: dtasker@chapteroneadvisors.com.au
M: +61 433 112 936

Find

Level 1, 34-36 Richmond Road,
Homebush West, NSW 2140
Australia

Call

Privacy Preference Center